Exactech Inc hits 2 month low after guidance announcement |
 |
 |
| By Staff and Wire Reports |
| Wednesday, 08 July 2009 16:44 |
 Exactech Inc. (NASDAQ:EXAC) announced after the bell Wednesday that it now expects to report second quarter revenues of approximately $43 million.
Earnings for the quarter are also expected to be below prior guidance. The company also adjusted its revenue forecast for the full year 2009 to between $167 million and $173 million. Shares are now down 0.77 on 17K shares. Exactech Inc. declined for the bulk of Wednesday morning and slipped further going into the close. The stock finished down by 0.66 at $13.52 and set a 2-month low. BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites            |
about 20 minutes ago
NHS education reforms 'lack detail' http://t.co/YiUKVEsS
about 22 minutes ago
Molecular 'on-off' switch for Parkinson's disease discovered http://t.co/wZ1N0xhq
about 22 minutes ago
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent http://t.co/CnJ8fKok
about 23 minutes ago
Roche's dalcetrapib failure fuels HDL debate, but CETP not done yet http://t.co/8H9JRnp9
about 23 minutes ago
Modest Gains Vanish As Stocks Reverse Lower http://t.co/AXlpfiAP
about 33 minutes ago
Reading: One More Reason the Market's Pullback is Not Over http://t.co/iSZ0oYUq
about 7 hours ago
Novo’s Insulin Pill Quest is Holy Grail for Novo: Health http://t.co/1NixK9Mx
about 7 hours ago
Bayer's Nexavar fails in lung cancer but FDA staff keen on Xarelto for ACS http://t.co/9VZRVqqD
Free Phone Trade Alerts
